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ABSTRACT
Periodontal diseases are a group of prevalent inflammatory diseases affecting the
tissues supporting and surrounding the teeth. In periodontal diseases, the inflammatory
response of the periodontal tissues is induced by a polymicrobial biofilm formed at or
below the gingival margin. Aggregatibacter actinomycetemcomitans, a Gram-negative
oral pathogen identified within this biofilm, is a causative agent of both chronic and
localized aggressive periodontitis. Dissemination of A. actinomycetemcomitans from the
oral cavity also initiates multiple systemic infections, including soft tissues abscesses,
pneumonia and endocarditis.
The innate immune response is the first line of defense against bacterial infections.
Dendritic cells, a group of professional antigen-presenting cells of the innate immune
system, express multiple surface C-type lectin receptors for the recognition of
glycoproteins associated with bacterial cells. Internalization of the organism by receptormediated endocytosis results in phagolysosome formation and degradation of the bacteria
for antigen presentation. Surface displayed antigens presented in an MHC complex to
antigen-specific T lymphocytes initiate an adaptive immune response.
A. actinomycetemcomitans expresses surface structures Extracellular matrix protein
adhesin A (EmaA), which extends from the cell envelope, and is composed of three
identical glycoproteins. The role of these structures in the interaction of A.
actinomycetemcomitans with dendritic cells is understudied. A series of experiments
presented here investigated the interaction of A. actinomycetemcomitans with dendritic
cells and the role of EmaA in this process. A. actinomycetemcomitans was internalized
and found to survive within dendritic cells. The internalization of bacteria was observed
to be associated with the presence of EmaA. Fewer emaA mutant bacteria were recovered
from dendritic cells when compared with the parent strain. In trans complementation of
the emaA mutant strain restored the interactive and survival capability of the bacteria.
These data suggest that EmaA mediates the interaction of A. actinomycetemcomitans
with dendritic cells. The migration of dendritic cells to draining lymph nodes suggests
that the EmaA-mediated internalization and intracellular survival is a potential
mechanism for the immune evasion and in vivo dissemination of A.
actinomycetemcomitans.
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CHAPTER 1: INTRODUCTION
1.1.   Oral health and diseases
Oral health is important for many physiological tasks, including the initial
processing of food, being able to speak clearly and fluently during communication, and
the expression of feelings [1]. Moreover, there is a strong linkage between oral health
and the overall health of the body [2]. The oral cavity is suggested to serve as a reservoir
for oral pathogens to disseminate and cause multiple systemic diseases [2]. Over 100
systemic diseases, including cardiovascular disease, diabetes and nutritional problems,
have oral manifestations [2].
The tooth is divided into two regions, the crown and the root. Both sections are
formed by dentin with a chamber inside containing dental pulp. The crown, the upper
region of the tooth, is composed of dentin and covered with enamel, a hard material
mainly composed of hydroxyapatite. The lower region comprising the root is covered
with cementum, which is composed of inorganic material (hydroxyapatite) and organic
portion (collagen and proteoglycans) [3]. In the mouth, the teeth are embedded in the jaw
and supported by the alveolar bone. Periodontal ligaments, a connective tissue mainly
composed of bundled collagen fibers, integrate the tooth root and the alveolar bone [3].
The gingiva is the soft tissue surrounding the tooth that acts as a seal for the root and the
alveolar bone. The shallow space between the gingiva and the tooth is called the gingival
crevice. Crevicular fluid, an inflammatory exudate in the gingival crevice with serumlike components, serves as a mechanism to defend the tissues against oral pathogens [4].
Inflammatory molecules, such as cytokines and chemokines in the crevicular fluid can
be analyzed to assess the extent of periodontal diseases [4].
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The oral cavity is a habitat that supports the growth of over seven hundred taxa of
microbes, including bacteria, fungi, protozoa and viruses [5]. Within minutes after we
clean the teeth, the proteins in the saliva coat the teeth and form a pellicle. This
proteinaceous film formed on the teeth surface provides a substrate for the formation of
a dental biofilm by oral microbes [6]. The composition of dental biofilms consists of oral
commensals and are typically non-pathogenic. Regular oral hygiene practices, including
teeth brushing, interdental flossing and regular check-ups prevent the build-up of
biofilms. The host immune system and the commensals in the biofilm also help to limit
the growth of oral pathogens and maintain oral health [6]. However, in situations such as
poor oral hygiene or immune deficiencies, an imbalance in the oral biofilm can initiate
an overgrowth of pathogens and results in multiple oral diseases, with the two major
forms being dental caries and periodontal diseases [6].
Dental caries are caused by specific Gram-positive bacteria including
Streptococcus mutans, Streptococcus sorbrinus and Lactobacillus casei [7]. These
bacteria are able to metabolize the fermentable carbohydrates in food debris, including
sucrose, fructose and glucose, to lactic acid [8]. Due to the low pH of the lactic acid, the
enamel and dentin will be dissolved, causing the demineralization of these materials and
the formation of dental caries [8]. Other oral pathogens can infect the tissues surrounding
the tooth, leading to periodontal diseases.
1.1.1. Periodontal diseases
Periodontal diseases are a group of inflammatory diseases affecting the tissues
surrounding and supporting the teeth including the cementum, periodontal ligament,
alveolar bone and gingiva [9]. Periodontal diseases are present in more than two thirds
2

of the population in the US [10]. All people above the age of 40 have some form of
periodontal diseases [10]. Risk factors for periodontal diseases include poor oral hygiene,
smoking, age and immunocompromised conditions [11, 12]. An early form of periodontal
diseases is gingivitis. Gingivitis is caused by the formation of dental biofilms and
subsequent immune response to the biofilms [13]. The symptoms of gingivitis include
redness, swelling, pain and bleeding of the gum [13]. Bad breath, or halitosis, is also a
sign of gingivitis [13]. There is no destruction of periodontal tissues in gingivitis and the
symptoms are reversible if treated. However, without proper treatment, gingivitis may
progress to a more severe form of periodontal diseases - periodontitis.
1.1.2. Periodontitis
In contrast to gingivitis, periodontitis is associated with irreversible destruction of
the periodontal tissues, including loss of the alveolar bone and periodontal ligaments [14].
This tissue destruction is caused by the immune response to specific species of bacteria
in the dental biofilm [14]. The inflammatory responses and secretion of pro-inflammatory
cytokines induce the proliferation of osteoclast cells and inhibit the proliferation of
osteoblast cells, which together lead to the destruction of the alveolar bone [15]. With
the progressive destruction of the periodontal tissues, the gingival sulcus becomes deeper
(from 1-2 mm to 3-7 mm) and forms a periodontal pocket. With the progression of tissue
destruction, the teeth lose the support of the periodontium and eventually fall out of the
jaw.
1.2.   Oral biofilm and periodontal pathogens
Biofilms are surface-attached or self-attached microbial communities embedded
in a matrix called extracellular polymeric substance (EPS) [16]. Biofilms are
3

advantageous for the microbes within the biofilm as it enhances microbial tolerance to
antibiotic agents, physical removal and attack by the immune system [17]. Formation of
the biofilm is initiated when a single planktonic bacterium samples the environment with
weak, non-specific interactions, such as van der Waals forces and charge-charge
interactions (Figure 1.1) [22]. If the environment is suitable, the bacterium adheres to the
substrate using surface proteins or structures including fimbriae (pili) and non-fimbrial
adhesins, which mediate much stronger interactions [19]. These bacteria (first colonizers)
will grow and replicate, forming a microcolony. At this stage, those bacteria that cannot
adhere to abiotic surfaces but are able to bind to other bacteria, termed secondary
colonizers, will co-aggregate and add to the biomass [22]. During growth of the
microcolonies, bacteria in the biofilm will secrete proteins, polysaccharides and DNA,
which together form the EPS that can also mix with the components from the
environment [17, 33].
EPS holds the microcolony together to protect the biofilm from the environment
and provides a relatively isolated environment within the biofilm. Bacteria in the biofilm
produce signaling molecules called autoinducers for communication with each other. The
signaling pathways or quorum sensing take place in the biofilm to coordinate gene
expression of the individual bacteria within the community. Therefore, the gene
expression profile of the biofilm-associated bacteria can be dramatically different from
bacteria grown in a planktonic fashion [18]. Horizontal gene transfer also occurs more
frequently within biofilms, allowing microbes within the biofilm to gain new potential
functions more rapidly and enhancing the stability of the biofilm [20].
4

When bacteria in the biofilm die and the cells lyse, DNA is released and integrated
into the EPS [22]. The microcolonies will continue to grow and form a three dimensional
mushroom-like structure, with channels in the base to allow for flow of nutrients
throughout the biofilm, thereby supporting bacterial growth. Microbes in the biofilm can
also disseminate and become planktonic, allowing for the disposal of the biofilm to
distant sites [21].

(a)

(b)

(c)

(d)

(e)

Figure 1.1. Development of a biofilm.	
  Formation of a biofilm is initiated when planktonic bacteria sample
the substrate and adhere to the substrate using adhesins (a). The attached bacteria grow and form
microcolonies together with the incoming bacteria (b). The microbes in the biofilm secrete proteins and
polysaccharides, which form a matrix covering the biofilm and protecting it from the environment (c). The
microcolonies grow and form a three-dimensional structure with channels on the bottom, allowing for the
flow of nutrients (d). At the late stage of biofilm formation, microbes can leave the biofilm and become
planktonic again (e). Image adapted from Monroe, D., PLoS Biol, 2007, 5(11):2458-2461

The surface of teeth and the salivary proteins coating teeth provide a hospitable
substrate for biofilm formation [22]. Gram-positive bacteria, usually oral commensals
such as Streptococcus parasanguinis and Streptococcus gondonii, act as early colonizers
in the biofilm formation and adhere to the surface of the teeth by fimbriae [22]. Following
5

maturation of the biofilm, the Gram-negative bacterium Fusobacterium nucleatum coaggregates with the early colonizers, acting as an anchor and bridge for the interaction of
multiple late colonizers onto the biofilm [22, 25]. With the formation of the biofilm,
bacterial metabolism changes the micro-environment, decreases the oxygen
concentration in the environment, and facilitates the growth of Gram-negative anaerobic
bacteria [22]. These Gram-negative bacteria include Porphyromonas gingivalis,
Treponema

dendicola,

Tennerella

forsythia,

and

Aggregatibacter

actinomycetemcomitans, which are associated with periodontitis [14].
1.3. Aggregatibacter actinomycetemcomitans
A. actinomycetemcomitans is a fastidious, capnophilic, non-motile coccobacillus
(bacterium with a morphology intermediate between cocci and bacilli). This bacterium
is a late colonizer in the formation of the dental biofilm. The average size of an A.
actinomycetemcomitans bacterium is 1.0 µm by 0.5 µm, as determined by electron
microscopy

(Figure

1.2)

[24].

In

addition

to

chronic

periodontitis,

A.

actinomycetemcomitans is closely associated with an acute form of periodontal disease,
localized aggressive periodontitis (LAP). LAP mainly affects individuals younger than
30 years old, with those of African descent being more susceptible [26]. The infection of
LAP is limited to specific teeth, i.e. incisors and first molars. LAP caused by A.
actinomycetemcomitans is able to lead to the loss of teeth in a few months if left untreated,
dramatically faster than the progression of chronic periodontal diseases, which may take
decades [26].
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0.5$μm

Figure 1.2. Fimbriated and afimbriated strains of A. actinomycetemcomitans. Electron microscopy
images of fimbriated (left) and afimbriated (right) A. actinomycetemcomitans are presented. White arrows
point to the bundled fimbriae, which are involved in biofilm formation and tissue adhesion. Images
courtesy of Dr. Teresa Ruiz (University of Vermont).

A. actinomycetemcomitans is able to disseminate from the oral cavity and enter the
circulation to cause multiple extra-oral infections including soft tissue abscesses,
pneumonia, bone inflammation and infective endocarditis [27]. The infections caused by
A. actinomycetemcomitans are attributed to multiple virulence factors, molecules that are
produced by the bacteria and contribute to the pathogenesis. These virulence factors
include protein toxins, lipopolysaccharide, and adhesins [27].
1.3.1. Virulence factors of Aggregatibacter actinomycetemcomitans
1.3.1a Toxins
Leukotoxin (LtxA) is a ~113 kDa secreted protein that is specific for leukocytes
[28]. It has ~50% sequence homology to the alpha-hemolysin of E. coli and is a member
of the repeats-in-toxin (RTX) family [29]. The name of the toxin family is based on the
glycine-rich repeats in the amino acid sequences. These glycine repeats bind calcium ions,
which are required for the activity of the toxin [29]. The biosynthesis and secretion of
the leukotoxin is mediated by the ltxCABD operon, which encodes the toxin molecule
7

(LtxA) and two components of a Type I secretion system (LtxB and LtxD) [30]. In the
ltx operon, the synthesized LtxA is modified by acylation on the two internal lysine
residues by LtxC. This acylation is essential for the activity of the LtxA molecule [31].
The secretion apparatus of leukotoxin is composed of three proteins: LtxB, LtxD
and TolC (TdeA). LtxB is an inner membrane ATPase and provides energy for the
secretion of LtxA [32]. Upon interaction with LtxA, LtxB undergoes conformational
changes and interacts with the periplasmic protein LtxD to form a channel in the
periplasm to allow for the transport of LtxA through the periplasm. The LtxA is finally
transported through a trimeric outer membrane pore formed by TdeA, a homolog of TolC
[32].
The production of leukotoxin is strain dependent: JP2 strains of A.
actinomycetemcomitans have a high production of leukotoxin, whereas strain 652 has
minimal leukotoxin production [34]. The major difference between the two groups is that
JP2 strains have a 530 bp deletion in the 3’ region of the ltx promoter [34]. The detailed
mechanism for the control of leukotoxin production at the genetic level is still under
investigation. An inner membrane protein MorC was found to be involved in the
secretion of leukotoxin; mutation of morC led to a significant decrease of LtxA
production without impacting the mRNA level of ltxA [53]. Interestingly, leukotoxin can
also be present in the outer membrane vesicles, which represent another delivery route
for this toxin [33]. The leukotoxin induces the apoptosis of the leukocytes, thus
contributing to the immune evasion of A. actinomycetemcomitans [29].
Cytolethal distending toxin (CDT) is an A-B toxin that is able to degrade DNA of
the host cells [35]. The effects of CDT on the host cells include stall of the cell cycle,
8

nuclear swelling, chromatin fragmentation, and eventually apoptosis of the host cell [35].
CDT is encoded on a three-gene locus cdtABC and the active toxin subunit is CdtB, which
has DNase I activity [38]. Although the roles of CdtA and CdtC are still unknown, these
proteins are required for maximal toxic activity [35]. Leukocytes are susceptible to CDT,
suggesting

that

CDT

also

contributes

to

the

immune

evasion

of

A.

actinomycetemcomitans.
1.3.1b Lipopolysaccharide
Lipopolysaccharide (LPS) is the major component of the outer membrane of Gramnegative bacteria, covering 75% of the bacterial surface and contributes to the
maintenance of membrane stability [39]. An LPS molecule is composed of lipid A, core
oligosaccharide and O-polysaccharide (O-PS). LPS molecules make up the outer leaflet
of the outer membrane together with outer membrane proteins [39]. Lipid A is composed
of a disaccharide decorated with fatty acids and it anchors the LPS molecule into the
bacterial membrane [39]. The core oligosaccharide links the O-PS to Lipid A. The O-PS,
or O-antigen, is composed of repeated glycan oligomers and is a major antigen for
antibody recognition [35]. The composition of the O-PS allows for the segregation of A.
actinomycetemcomitans into seven serotypes (a-g), with each serotype encoding an OPS with unique composition and structure [41, 42]. Serotype b and c are the most
prevalent strains associated with diseases caused by A. actinomycetemcomitans [41].
Dendritic cells co-cultured with serotype b strains expressed higher level of cytokines,
including IFNγ, TNFα, IL-1β, IL-12, IL-6, and IL-23 compared to the cells co-culture
with equal amount of serotype a and serotype c strains [43]. The results held true for
dendritic cells co-cultured with purified LPS from the three serotypes individually,
9

suggesting that the different cytokine expression levels are attributed to the LPS of the
different serotypes [43].
1.3.1c Non-fimbrial adhesins
A. actinomycetemcomitans produces three known non-fimbrial adhesins: Aae,
ApiA and EmaA. All of these adhesins are autotransporter proteins, which have all the
information encoded on the amino acid sequence for outer membrane translocation and
secretion of the protein [36]. An autotransporter protein is composed of an N-terminal
signal sequence, a passenger domain and a C-terminal membrane anchor domain [36].
Autotransporters are divided into three classes: Type Va, Type Vb and Type Vc
according to different mechanisms for secretion [36]. Type Va, or conventional
autotransporter protein, encodes a membrane anchor domain containing 14 β-strands.
This domain is able to form a β-barrel in the outer membrane to allow for the
translocation of the passenger domain. The adhesin Aae is a 90 kDa monomeric Type Va
autotransporter. Type Vb autotransporters have separate genes encoding the passenger
domain and membrane anchor domain [36]. Both domains have signal sequences for the
inner membrane targeting and translocation. After translocating into the periplasm, the
two domains interact with each other and initiate membrane translocation. Type Vc
proteins, also called trimeric autotranporters, contain four β-strands in the translocator
domain that are required to trimerize to form a complete β-barrel, so the mature
molecules are homotrimers [36]. The other two characterized non-fimbrial adhesins in A.
actinomycetemcomitans are the 34 kDa ApiA and the 202 kDa EmaA, which are both
Type Vc autotransporters [44].
10

Both Aae and ApiA mediate the adhesion of A. actinomycetemcomitans to buccal
epithelial cells. Double knockout of aae and apiA completely abolished the epithelium
adhesion of this bacterium [37]. Additionally, ApiA also contributes to the resistance of
A. actinomycetemcomitans to the complement system [44]. EmaA is an adhesin that
mediates binding of A. actinomycetemcomitans to the extracellular matrix (ECM). The
detailed characteristics of EmaA will be described in Chapter 1.5.
1.4. Fimbriae of Aggregatibacter actinomycetemcomitans
Clinical isolates of A. actinomycetemcomitans collected from periodontal pockets
are characterized by a rough colony surface, irregular edge and a star shaped internal
structures in the center of the colony [24, 45]. The colony is not easily disrupted by
physical removal with an inoculating loop. When grown in liquid culture, these clinical
strains grow on the surface of the container instead of forming a suspension in the liquid
phase, leaving the culture supernatant essentially clear (Figure 1.3). These distinguishing
phenotypes are attributed to the production of long bundled structures termed fimbriae
[45, 46]. The fimbriae produced by A. actinomycetemcomitans are 5-7 nm in diameter
and can be several micrometers in length (in comparison with 1 µm, which is the average
size of an A. actinomycetemcomitans cell) [46]. The fimbriae are involved in the autoaggregation, adhesion to substrates and biofilm formation [46].
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Figure 1.3. Biofilm formed by fimbriated A. actinomycetemcomitans. Fimbriated (left) and afimbriated
(right) A. actinomycetemcomitans were grown in liquid media overnight and the supernatant was removed.
The biofilms formed on the surface of the tubes were stained with ethidium bromide and visualized by UV.
Image adapted from Figurski D. H. et al. INTECH Open Access Publisher, 2013.

1.4.1 The biosynthesis and secretion of fimbriae in A. actinomycetemcomitans
The fimbria of A. actinomycetemcomitans is a member of the type IV pili family
and is synthesized and secreted by a 14 gene locus called the Tight adherence (Tad) locus
(Figure 1.4) [49]. The secretion apparatus is homologous to the type II secretion system,
which is a common secretion system used by multiple Gram-negative bacteria including
P. aeruginosa and Klebsiella pneumoniae for the secretion of virulence factors such as
proteases and lipases [50, 51]. The first gene in the locus, flp-1, encodes a 6.5 kDa protein
Flp1, which is the subunit of the fimbriae [52]. The Flp1 subunit protein has a long leader
sequence, a hydrophobic domain involved in polymerization of the subunit and a C12

terminal functional domain involved in the adhesion activity [52]. The subsequent gene
flp-2 is a pseudogene and is the only dispensable gene in this locus [53]. The following
gene, tadV, encodes a prepilin peptidase that cleaves the leader peptide of Flp1 during its
maturation [54].

A

B

Figure 1.4. Tad locus and fimbriae secretion. (A) A fourteen-gene locus is involved in the biosynthesis
and secretion of the fimbriae, which is responsible for the formation of the biofilm and adhesion to host
tissues. (B) Eleven genes in this locus encode proteins that form a secretion system spanning the cell
envelope to allow for the secretion of the fimbriae. Detailed roles of each protein are described in the text.
Image adapted from Tomich, M. et al, Nature Reviews Microbiology 2007. 5:363-375.

The next genes encode the secretion system of the fimbriae. rcpC encodes an inner
membrane protein that is suggested to be involved in the post-translational modification
of Flp1 [54, 55]. rcpA encodes a protein forming an outer membrane pore that allows for
the secretion of the assembled fimbriae [55]. tadA encodes a protein that has homology
to an ATPase and it provides the energy for the secretion and biosynthesis of the fimbriae
[53, 55]. TadE and TadF are called pseudopilins and their leader peptides are also cleaved
13

by the prepilin peptidase TadV [54, 55]. Mature TadE and TadF together form a channel
structure spanning the periplasm to allow for the secretion of the fimbriae [55]. The other
genes within the Tad locus, although their specific functions are unknown, are still
required for the biosynthesis and secretion of the fimbriae as demonstrated by mutagenic
analyses [55, 56].
During laboratory practice, the production of fimbriae is irreversibly lost after
repeated culture in liquid media and these bacteria become afimbriated strains [47]. The
colonies formed by afimbriated strains are smooth and easily disrupted, with the star
shaped internal structure absent in the colony [48]. The afimbriated strains of A.
actinomycetemcomitans grow in suspension in liquid culture and are therefore easier to
genetically manipulate.
1.4.2 The role of MorC in fimbriae biosynthesis.
MorC is a 141 kDa protein encoded by a 3.8 kb gene [57]. It is a conserved protein
in hundreds of species of Gram-negative bacteria, including H. influenzae, E. coli and P.
aeruginosa [57]. The mutation of morC in A. actinomycetemcomitans leads to multiple
phenotypical changes, including decreased membrane stability, decreased leukotoxin
secretion and morphological change of the outer membrane [57]. Interestingly, morC
mutation was found to result in a decreased level of expression of the genes in the Tad
locus as predicted by a quantitative proteomics analysis [58]. The decreased fimbriae
expression in the morC mutant strain was subsequently verified by tagging the fimbrial
subunit with a T7 tag followed by ELISA detection using an anti-T7 monoclonal
antibody (Personal communication, Mintz, K. P.). The detailed mechanisms of MorC in
maintaining the optimal fimbriae biosynthesis and secretion remain under investigation.
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1.5. Extracellular matrix protein adhesin A (EmaA)
EmaA

is

a

non-fimbrial

adhesin

that

mediates

the

binding

of

A.

actinomycetemcomitans to collagen, the most abundant protein in the human body [59].
EmaA is the only known adhesin that has specific collagen binding activity in A.
actinomycetemcomitans, and it is one of the few adhesins identified in oral bacteria that
binds to extracellular matrix [60]. EmaA was first identified from a transposon library
screen, in which mutants showed decreased collagen binding activity [59]. Subsequent
genotypic analysis of the mutants confirmed that the transposon landed in a 6.5 kb gene
encoding a 202 kDa protein [59]. EmaA is an autotransporter protein secreted by Type
V secretion system, and the secretion is dependent on chaperones including SecB and
DnaK [61].
The EmaA molecule is composed of an N-terminal signal sequence, a passenger
domain and a C-terminal membrane anchor domain (Figure 1.5). The signal sequence is
composed of 56 amino acids, dramatically longer than the average size (5 – 30 amino
acids) of signal peptides [62]. The residues within the signal sequence are associated with
the optimal secretion of EmaA, as signal sequences containing internal deletions lead to
decreased membrane localization of EmaA at 37 °C or higher temperatures and decreased
collagen binding activity [62]. The passenger domain is divided into a functional domain
and a long stalk domain. The functional domain, which consists of amino acids 70 – 384,
forms an ellipsoidal structure and confers collagen binding activity [63]. The stalk
domain supports the functional domain and contains multiple coiled-coil sequences for
the oligomerization of the monomers [64]. There are seven neck sequences present in the
passenger domain, which stabilize the molecule and provide transitions between each
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segment [63]. The membrane anchor domain contains β-barrels that form a pore upon
oligomerization on the outer membrane of the bacteria for the translocation of the
passenger domain. The trimerized EmaA molecules form antennae like structures
extending ~100 nm from the surface of the bacteria [64].

A

B

Figure 1.5. Schematic diagram and electron micrograph of EmaA. (A) Schematic model of the EmaA
molecule. The N-terminal functional domain is subdivided into three subdomains (SI-SIII). Seven neck
sequences (N1-N7) are identified within the passenger domain. SP: signal peptide, MAD: membrane
anchor domain. (B) EmaA structures (white arrow) are identified on the surface of A.
actinomycetemcomitans. Scale bar: 100 nm. Images adapted from Ruiz, T. et al. (2006). Infect. Immun.
74:6163-70.

1.5.1. Collagen binding activity
Collagens are the structural components of connective tissues, including tendon,
skin and ligaments [65]. Collagens are also the most abundant protein in the human body,
16

including periodontal tissues and heart valves [65]. In oral tissues, collagens are
synthesized by fibroblasts and lie under the epithelium layer. Fibrillar collagens,
including collagen type I, II, III, and V are substrates for the binding of EmaA, with type
V collagen having the highest affinity [66, 67]. EmaA is able to bind to collagen both in
vitro and in vivo [59, 60]. The collagen binding activity of EmaA was first identified
using acid solubilized collagen as substrate in an enzyme-linked immunosorbent assay
[59]. An emaA mutant shows at least 50% to 60% reduction in binding to solubilized
collagen compared to the wild type strain [64]. This binding deficiency is recovered by
complementation with the emaA gene in trans, confirming the role of EmaA in collagen
binding in vitro [59].
The binding of EmaA to native collagen was demonstrated both ex vivo and in vivo
using either isolated heart valves or an infective endocarditis model [60]. Both wild type
and emaA mutant strains bind heart valves at a comparably low level when the
endothelium remains intact [60]. However, if the endothelium is disrupted by trypsin
treatment (ex vivo) or catheterization (in vivo), wild type A. actinomycetemcomitans
binds avidly to the decellularized rabbit heart valves. In contrast, the binding of the emaA
mutant is five fold less and ten fold less compared to the wild type in ex vivo and in vivo
conditions, respectively [60]. These analyses collectively suggest the role of EmaA as a
virulence determinant for the initiation of infective endocarditis and many other
infections.
The functional domain of EmaA is predicted to be in the N-terminal region of this
molecule. A series of mutants in this region has been constructed and introduced into the
emaA mutant strain to determine the collagen binding domain of the EmaA [63]. The
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collagen binding domain is mapped to amino acids 70-384, where multiple collagen
binding motifs are present [63]. The emaA mutants that contain internal deletions in this
region still produce surface structures, but lack the collagen binding activity, suggesting
that this domain is involved in collagen binding, but not the secretion or oligomerization
of the protein [54]. The mutation of a single amino acid, G162S, leads to a complete loss
of the collagen binding activity and the ellipsoidal head structure [63]. Interestingly, the
mutation of the same glycine to alanine does not affect the collagen binding activity,
suggesting that hydrophobicity of the amino acid in the collagen binding motif is
important for the activity of EmaA [63].
1.5.2. Serotype association of EmaA
The genotype of emaA is associated with the serotype of the bacteria [68]. The
serotype b and serotype c strains encode a full-length EmaA, with a 6.5 kb gene encoding
a 202 kDa protein containing 1965 amino acids [68]. The serotype d and a third of
serotype a strains tested encode an intermediate form of EmaA, which contains a 279
amino acid in-frame deletion in the stalk domain [68]. The intermediate form of EmaA
is suggested to be shorter than the full-length counterpart, possibly due to this internal
deletion. Interestingly, the intermediate form of EmaA retains the in vitro collagen
binding activity, as determined by a 3D matrigel assay [68]. The remaining sequenced
serotype a, serotype e and f strains contain premature stop codons in the coding region
of emaA, which lead to incomplete synthesis of the membrane anchor domain [68]. Since
the membrane anchor domain is required for the translocation of the passenger domain
and the membrane location of the molecule, these strains do not express EmaA on the
bacterial surface and do not bind to collagen [68].
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Figure 1.6. Schematic diagram of EmaA molecular forms. Up: Full-length EmaA, bottom: intermediate
EmaA. Yellow: signal sequence; white: neck sequence; pink: coiled-coil domain; red: membrane anchor
domain. Dashed region correlates to a 279 amino acid internal deletion in the intermediate form of EmaA.
The percentiles indicate the sequence homology of the intermediate EmaA to the full-length counterpart.

1.5.3. Glycosylation of EmaA
EmaA is found to be glycosylated and the glycosylation process is associated with
the LPS biosynthesis pathway [70]. The role of LPS biosynthesis in EmaA glycosylation
was revealed by both genetic and pharmacological analyses [70]. The O-PS of the
serotype b A. actinomycetemcomitans is composed of repeating L-rhamnose and Dfucose with N-acetyl-D-galactosamine attached to the L-rhamnose. rmlC is the gene
encoding a TDP-rhamnose 3,5-epimerase, an enzyme required for L-rhamnose
biosynthesis. The mutation of rmlC leads to decreased molecular weight of EmaA and
the loss of reactivity to a rhamnose binding lectin, suggesting the mutation of rmlC leads
to the loss of EmaA glycosylation. Complementation of rmlC in trans restored the
phenotypes of EmaA. Mutation of the genes encoding the ATP-binding cassette (ABC)
transporter mediating the export of LPS (wzt) and the O-PS ligase (waaL) that links the
O-PS to the Lipid A core also lead to the same phenotype, suggesting the role of LPS
biosynthesis pathway in EmaA glycosylation [70].
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The role of LPS biosynthesis in EmaA glycosylation is further confirmed by
pharmacological analyses [70]. Bacitracin is an antibiotic that disrupts the synthesis of
the lipid carrier of the O-PS. Bacitracin treatment of the wild type A.
actinomycetemcomitans leads to a decreased molecular weight of EmaA. This molecular
weight decrease is reversed by growth of the bacitracin-treated bacteria in fresh media
without bacitracin. These analyses collectively demonstrated the role of LPS biosynthesis
in EmaA glycosylation [70]. This glycosylation mechanism appears to be unique to
EmaA,

as

another

autotransporter

adhesin,

ApiA,

expressed

by

A.

actinomycetemcomitans is not affected by mutation of the rmlC gene [70].
Glycosylation is important for the protein structure as it facilitates the correct
folding, resistance to enzyme degradation and ensures the activity of the modified protein
[72-74, 79-81]. The glycosylation of EmaA is required for the stability and function.
Surface exposed EmaA are decreased up to 50% in the glycosylation deficient strains
compared to the wild type, whereas the mRNA level of emaA is not changed [71].
Therefore, decreased production of EmaA is not due to a decrease in the transcription of
the gene [71]. The collagen binding activity of the EmaA from the mutant is also
decreased, as revealed by the collagen binding assay. Overexpressing emaA in the mutant
strain does not complement the collagen binding defect, suggesting that the decreased
collagen binding activity is not due to a decreased protein expression level [71].
1.6. Periodontitis and immune response
1.6.1 The innate immune system
The innate immune system is the first line of defense of the body against pathogens
[74]. Innate immunity occurs early (0-4 hours after infection) upon pathogen invasion
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and operates with less specificity compared to adaptive immunity, which is more specific
and longer-lasting [74]. The outermost barrier of the innate immune system is the
epithelial layer, which secretes antimicrobial peptides (defensins, cathelicidins,
protegrins) and antimicrobial enzymes (lysozymes, secretory phospholipase A2) [74].
The complement system is also a major component of innate immunity. The
complement system mediates the direct killing of pathogens by forming membrane attack
complexes on the surface of the bacteria, which subsequently leads to the lysis of the
bacteria. Some fragments of the complement molecules, such as C3a and C5a, are
efficient inducers of the inflammatory response [74]. The complement molecules also
bind to the surface of the bacteria and this opsonization induces engulfment by
phagocytic cells. Immune cells involved in phagocytosis of pathogens include
neutrophils, macrophages and dendritic cells [74]. These cells recognize and capture
pathogens through phagocytosis, macropinocytosis and receptor-mediated endocytosis
using C-type lectin receptors and Fc receptors [89]. When the pathogens are taken up
into the phagosomes, lysosomes are directed and fused with the phagosomes, forming
phagolysosomes. The pathogens are degraded in the phagolysosome, processed to
antigens, and subsequently presented to T cells in MHC complexes [76].
1.6.2 Dendritic cells
Dendritic cells are a group of professional antigen presenting cells playing a key
role in the innate immune system [76]. Dendritic cells were so named because of their
branched processes that resemble the dendrites of neurons. Dendritic cells have the
ability to open the tight junctions of the epithelial layer and send dendrites out to sample
the environment, thus playing a sentinel role in the immune system [77]. Immature or
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inactivated dendritic cells have a high capacity for capturing particles. After antigen
uptake, the dendritic cells become mature, with a decreased phagocytic capability and
increased expression of MHC-II-antigen complexes and co-stimulatory molecules on the
surface [76]. The mature cells migrate to secondary lymphoid organs, where they present
the antigens to antigen-specific T lymphocytes, mainly CD4+ T cells, to initiate the
adaptive immune response [76]. In addition, dendritic cells also express MHC-I
molecules on the surface and present antigens to CD8+ T cells by cross-presentation.
Therefore, dendritic cells are a major cell type that bridge the gap between the innate and
adaptive immune responses [78].
1.6.3. The interaction of dendritic cells with bacteria
Multiple bacteria, including obligate and facultative intracellular pathogens, are
internalized and survive inside dendritic cells. These bacteria include Mycobacterium
tuberculosis, Listeria monocytogenes, Bordetella bronchiseptica and Porphyromonas
gingivalis [83-87]. The recognition of pathogens is accomplished by a group of receptors
called pattern recognition receptors (PRRs) that recognize pathogen-associated
molecular patterns (PAMPs) [79]. Among these PRRs, the capture of the pathogen is
conducted by a group of C-type lectin receptors [88]. These receptors have carbohydrate
recognition domains that interact with the glycan moieties on the pathogens. Some well
characterized C-type lectins include Langerin, Dectin-1 and Dendritic cell-specific
ICAM-3 grabbing nonintegrin (DC-SIGN) [89].
Internalized bacteria have evolved various mechanisms to survive inside dendritic
cells and delay and/or decrease the level of the antigen presenting process [94]. These
mechanisms include the secretion of a series of effector molecules through type III and
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Type IV secretion systems to the host cell, to prevent or delay the fusion between the
phagosome and lysosome and to manipulate the cytoskeleton of the host [90]. For
example, Salmonella enterica serovar Typhimurium (S. Typhimurium), a facultative
intracellular bacterium associated with gastrointestinal infections, secrete multiple
virulence factors that are encoded on a gene locus called Salmonella pathogenicity island
2. These effector molecules are delivered from the Salmonella containing vacuole to the
host cell by a type III secretion system [94]. These effector molecules cooperate to
subvert host cell singaling and prevent the fusion of the lysosome to the phagosome,
which disrupts the antigen processing and contributes to its immune evasion. Thus, the
bacteria utilize the dendritic cells as vehicles or “Trojan horses” for their survival,
replication and tissue dissemination to the non-oral tissues while maintaining evasion
from the host immune systems [90].
Listeria monocytogenes, a bacterium involved in food borne illness, is found to
enter dendritic cells and persist inside dendritic cells for at least 24 hours [95]. Those
intracellular bacteria are able to manipulate the host cell cytoskeleton to form actin
polymers to facilitate their intracellular movement and cell-to-cell dissemination [95]. In
contrast to what was found in Salmonella, L. monocytogenes strains that lack the
production of some virulence factors such as listeriolysin O have a better survival rate
inside dendritic cells compared to the wild-type counterpart [95]. This finding is in
correlation with the fact that L. monocytogenes is able to survive and replicate in the
phagosome, thus preventing the immune recognition and the subsequent responses of the
host cells.
23

Bordetella bronchiseptica, a Gram-negative bacteria associated with respiratory
infections, is found to be able to be internalized into dendritic cells and survive in
dendritic cells for at least 72 hours [96]. Interestingly, the results suggest that B.
bronchiseptica utilize multiple adhesins, including those encoded by the bvg locus and
those that are independent of the locus, to interact with different receptors on dendritic
cells [96].
According to the previous research, A. actinomycetemcomitans is not able to
survive in the other two groups of phagocytic cells in the innate immune system, i.e.
neutrophils

and

macrophages

[90,

91].

However,

the

interaction

of

A.

actinomycetemcomitans with dendritic cells had not been characterized. In this research,
we used a dendritic cell internalization assay to investigate the interaction of this
bacterium with bone marrow derived dendritic cells. A. actinomycetemcomitans was
found to be internalized into dendritic cells and survived within dendritic cells.
Furthermore, a surface glycoprotein EmaA was found to play an important role in the
interaction and/or the survival of the bacterium inside dendritic cells.
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CHAPTER 2: RESEARCH DESIGN AND RESULTS
2.1. Materials and methods
Bacterial strains and growth conditions. The bacterial strains and plasmids used
in this research are listed in Table 1 (Page 46) and Table 2 (Page 48), respectively. All A.
actinomycetemcomitans strains were streaked onto TSBYE plates (3% Trypticase soy
broth, 0.6% Yeast extract, 1.5% agar; Beckton Dickinson, Franklin Lakes, NJ) from
frozen stocks and grown to a confluent biofilm (36 - 48 h) at 37°C in a humidified 10%
CO2 atmosphere. Antibiotics were added to a final concentration of 100 µg/mL ampicillin,
50 µg/mL kanamycin and 50 µg/mL spectinomycin, when necessary. Unless mentioned
elsewhere, all Escherichia coli strains were grown with agitation at 37°C in Luria-Bertani
(LB) broth (1% tryptone, 0.5% yeast extract and 0.5% NaCl; Becton Dickson, Franklin
Lakes, NJ) containing 100 µg/mL ampicillin, 50 µg/mL spectinomycin when appropriate.
Construction of the isogenic mutant strains. The emaA mutant strain was
constructed by allelic replacement via conjugation following the published procedure
with modifications [2]. An internal fragment of emaA corresponding to nucleotides 801285 was amplified and disrupted with the spectinomycin resistance gene aad9 at
nucleotide 609. This disrupted emaA fragment was introduced into the EcoRI site of a
conjugative vector pVT1460, making the plasmid pKM524. The new plasmid was
transformed into the E. coli strain KM482 which requires diaminopimelic acid (DAP) for
growth to construct the donor strain. The wild type fimbriated clinical isolate VT1257
(serotype b) was used as the recipient strain.
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The recipient cells were grown on a TSBYE plate by confluency streaking for 24
hours, collected using a sterile glass slide and resuspended in 1 mL TBSYE. The donor
cells were grown in LB broth supplemented with 0.3 mM DAP until an OD600 = 0.3. One
milliliter of donor cells were then collected, washed once with TSBYE and resuspended
in 250 µL TBSYE. The recipient cells and donor cells were mixed in a 2.5:1 ratio and
the conjugation mixture was spotted onto a TSBYE plate supplemented with 0.3 mM
DAP. The plate was incubated for 15 min at room temperature, followed by 5 h
incubation in a humidified 10% CO2 atmosphere at 37°C to allow for the conjugation.
Following the incubation, 1 mL of TSBYE was added to the plate and the cells were
collected with a sterile glass slide, serial diluted, spread onto TSBYE plates containing
50 µg/mL spectinomycin and incubated for 72 h.
The spectinomycin resistant colonies were replica-plated onto TSBYE plates
containing either 100 µg/mL kanamycin or 50 µg/mL spectinomycin. The
transconjugants that were resistant to spectinomycin but sensitive to kanamycin were
tested for the correct integration of the aad9 gene into the chromosome by PCR. Genomic
DNA from the transconjugants was isolated using Puregene DNA extraction Kit (Gentra
Systems, Minneapolis, MN). The correct integration of the aad9 gene was verified by
PCR using the primers: CBP1-UpF: 5’-ACATGCATGCAACAAATCGCCGTCATCGCC-3’ and Spc-2R: 5’-CTCTTGCCAGTCACGTTACG-3’.
To confirm the unique role of EmaA in dendritic cell internalization, an isogenic
mutant for morC was generated using the same protocol as described above using the
following plasmid construct. The morC mutation construct contains 1 kb DNA fragment
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upstream and 1 kb fragment downstream of the morC gene, with the spectinomycin
resistance gene aad9 in between. The mutation construct was ligated with the mobilizable
plasmid pVT1460 to make the plasmid pKM551. The E. coli strain KM482 was
transformed with pKM551 to construct the donor strain. The wild type A.
actinomycetemcomitans VT1257 was used as the recipient strain. The conjugation was
conducted as described above and the genotype of the mutant was verified by PCR using
the following primers: Omp67F: 5’-TCTGGACGTATTGCTTTATCCGC-3’ and Spc2R: 5’-CTCTTGCCAGTCACGTTACG-3’.
Complementation of the emaA mutant strain. The complementation of the emaA
mutant was performed by transforming pKM9, a shuttle plasmid containing the complete
sequence of the full-length emaA and 500 bp of the upstream region, into the emaA
mutant strain by electroporation as described [4]. The transformants were selected on
TBSYE-agar plates containing 100 µg/mL kanamycin and the presence of the plasmid
pKM9 was verified by colony PCR using the following primers: pKM1F: 5’CTTTATGCTTCCGGCTCGTA-3’

and

CBP1-1259R:

5’-

GGAGAGAAAT-

AATAACGGGGC - 3’.
Construction of the GFP-expression strains. A. actinomycetemcomitans strains
VT1257, KM696, KM700 were transformed with a broad-host plasmid harboring a gene
encoding the green fluorescence protein (GFP) of Aequorea victoria (pKM542) for
confocal laser scanning microscopy and fluorescence activated cell sorting (FACS)
analyses [3]. Briefly, A. actinomycetemcomitans strains were grown on TSBYE plates
(antibiotics added as appropriate) until confluency (24 - 36 h). Two plates of bacteria
were scraped from the plates with a sterile glass slide and washed in electroporation
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buffer (0.57 mM KH2PO4, 2.43 mM K2HPO4 and 272 mM sucrose in 15% (v/v) glycerol)
three times at 4°C. The cell suspension was then mixed with 0.5 µg plasmid and the
electroporation was performed at 2.5 kV. The bacteria were recovered in 1 mL TSBYE
broth at 37°C for 4 h and spread onto TSBYE plates containing 100 µg/mL of ampicillin
for the selection of the transformants. The plates were incubated for 3 days and the
transformants were verified by the expression of green fluorescence using a fluorescent
microscope.
Immunoblotting analyses. The emaA mutant and the morC mutant were further
characterized by immunoblotting to confirm the lack of expression of the proteins of
interest. Bacterial strains were grown in 100 mL TSBYE in T175 tissue culture flasks in
at 37°C in a humidified 10% CO2 atmosphere for 16 hours. Spectinomycin was added to
a final concentration of 50 µg/mL for the maintenance of the mutant. The cells were
scraped from the surface of the culture flasks, suspended in PBS and lysed using a French
pressure mini cell at 18,000 psi for three times at 4°C. The cell lysate was clarified by
centrifugation at 12,000 × g to remove the intact cells. Membranes fractions were
collected by centrifugation at 100,000 × g at 4°C. The pellet containing the whole
membrane fraction was resuspended with 250 µL PBS and the protein concentration of
the suspension was determined by BCA Protein Assay Kit following the manufacturer’s
protocol (Pierce) with bovine serum albumin as the standard.
For the detection of EmaA, 250 µg protein of each sample was separated in a 5%
polyacrylamide-SDS gel at 40 V for 3 h. For the detection of MorC, 250 µg protein of
each sample was separated in a 4-15% gradient polyacrylamide-SDS gel at 80 V for 1.5
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h. Proteins were subsequently transferred onto PVDF membranes at 100 mA for 2 h. The
membranes were blocked with 5% non-fat milk and incubated with either 15 µg/mL antiEmaA stalk monoclonal antibody or 1 µg/mL affinity purified anti-MorC antibody at
room temperature for 1 h. The membrane was washed vigorously in 1 × TBST (0.5%
(v/v) Tween-20 in TBS) for 3 times, 5 min each. The membrane was then probed with
horseradish peroxidase (HRP) conjugated goat-anti-mouse secondary antibody for EmaA
detection and HRP conjugated goat-anti-rabbit secondary antibody for MorC at room
temperature for 1 h. The immune complexes were detected by Pierce West Femto
detection reagent.
Dendritic cells culture. Mouse bone marrow derived dendritic cells (mBMDCs)
were prepared according to published protocols with modifications [1]. Briefly,
hematopoietic cells from mouse bone marrow of freshly isolated mouse femurs were
isolated by flushing the bone with PBS containing 2% fetal bovine serum using 1 mL
syringe. The cells were separated from debris and the cell aggregates were disrupted by
repeated pipetting. The bone marrow hematopoietic cells were grown and differentiated
to dendritic cells in complete dendritic cell media (RPMI-1640 supplemented by 10%
fetal bovine serum, 0.1 mM sodium pyruvate, 0.1 mM folic acid, 0.1 mM glucose, 50
µM β-mercaptoethanol, 100 U/mL penicillin, 100 U/mL streptomycin and 20 ng/mL
granulocyte macrophage – colony stimulating factor (GM-CSF) ) at 37°C in a humidified
5% CO2 atmosphere for 10 days. Conditioned media were removed and 15 mL new
media were added into the culture every 2 days. Prior to each experiment, dendritic cells
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were collected by centrifugation at 450 × g for 10 min, washed and resuspended with
antibiotic-free complete dendritic cell media.
Dendritic cell internalization assay. The internalization assay was performed
following published protocols with modifications to study the interaction of A.
actinomycetemcomitans with dendritic cells [5, 6]. Dendritic cells (3 × 105) were seeded
into each well of 12-well plates in 1 mL antibiotic-free complete dendritic cell media.
Bacterial strains were grown on agar plates (for A. actinomycetemcomitans, antibiotics
added as appropriate), or in LB broth containing 100 µg/mL ampicillin (for E. coli strain
KM542). The bacteria were collected, washed once with 1 × phosphate buffered saline
(PBS) and resuspended in antibiotic-free complete dendritic cell media.
Bacterial input of each strain was normalized to protein concentration to ensure
equivalent inoculum to the dendritic cells. Bacteria corresponding to 40 µg total protein
were inoculated into each well and co-cultured with dendritic cells for 2 h in a humidified
5% CO2 atmosphere at 37°C to allow for the internalization. Gentamicin (100 µg/mL)
was subsequently added to the co-culture system for the remainder of the assay to kill all
the extracellular bacteria.
Confocal laser scanning microscopy. The internalized bacteria in dendritic cells
were examined by confocal laser scanning microscopy. The dendritic cells were grown
on sterile glass coverslips and co-cultured with GFP-labeled bacteria. The dendritic cells
with or without the bacteria were stained with 10 µM Hoechst 33324 and MitochondriaRed (Invitrogen) to label the nuclei and mitochondria, respectively. The stained dendritic
cells were then washed with PBS and fixed with 2.5% formaldehyde (Ted Pella, Redding,
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CA). The cell samples were imaged using an LSM 510 Meta confocal laser scanning
microscope (Zeiss, Goettingen, Germany), attached to an Axiovert 200 M inverted light
microscope (Zeiss) using a 63× oil immersion objective lens. The internalized bacteria
were visualized by the green fluorescence produced by the GFP. For live imaging,
dendritic cells co-cultured with GFP-labeled bacteria were mounted into a heated
chamber with humidified 5% CO2 atmosphere. Images were taken at 1 min intervals and
overlaid with phase contrast images.
Flow cytometry. Approximately 1 × 105 dendritic cells were transferred into tubes,
washed once with PBS and fixed with 2.5% paraformaldehyde. The fluorescent cells
were then analyzed using a BD LSR II flow cytometer (Becton Dickinson) with a single
excitation wavelength (488 nm) and band filters for FITC (525 nm). The cell population
was classified for size (forward scatter) and granularity (side scatter) and 5,000 cells were
evaluated per condition. Dendritic cells treated with an actin polymerization inhibitor,
Cytochalasin D (5 µg/mL), were included in the experiment to determine the role of actin
polymerization in bacteria internalization.
Live bacteria recovery. Dendritic cells co-cultured with bacteria corresponding to
40 µg of total protein for 3 h were collected by centrifugation at 450 × g for 10 min and
lysed with dendritic cell lysis buffer (0.5% (v/v) Triton X-100 in PBS). The cell lysates
were serial diluted with TSBYE and spread onto TBSYE plates to recover the live
internalized bacteria. The plates were incubated at 37°C in humidified 10% CO2 for 48
– 72 h and the colonies on each plate were enumerated [6].
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Statistical analysis. All the analyses were performed in duplicates in this study
and repeated a minimum of 2 times. Results are presented as mean ± standard deviation.
Student’s t-test was used for the data analysis and a p-value < 0.01 was used as the
threshold for statistical significance.
2.2. Results
Detection of EmaA and MorC by immunoblotting. For the detection of EmaA
and MorC, we used afimbriated wild type A. actinomycetemcomitans and respective
isogenic mutants as controls. The wild type of both afimbriated strain and fimbriated
strain showed strong immune reactivity in the immunoblotting for both EmaA and MorC
(Figure 2.1, 2.2). The mutant strains showed no visible detection of the proteins of
interest. These data collectively showed at protein level that the mutants were
successfully constructed by allelic replacement.
Confocal laser scanning microscopy of co-cultured dendritic cells. We
examined the intracellular localization of the GFP-labeled A. actinomycetemcomitans in
dendritic cells by laser scanning confocal microscopy. The mitochondria of the dendritic
cells were stained with Mitotracker-Red to define the cytoplasm (Figure 2.3) and the
nuclei were counterstained with Hoechst 33324 (Figure 2.3). The confocal microscopy
images were overlaid with phase contrast images to show the location of the cells (Figure
2.3). Digital images acquired with a 63× oil immersion lens showed fluorescent bacteria
inside dendritic cells from the images taken 3 h and 6 h after co-culture (Figure 2.3),
suggesting that the bacteria were internalized into dendritic cells within 3 hours.
Live imaging of the dendritic cells co-cultured with A. actinomycetemcomitans.
Live imaging of the dendritic cells co-cultured with GFP-labeled VT1257 was performed
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with a confocal microscope equipped with a heated stage and a humidified 5% CO2
chamber. Images of the same field were taken in one-minute intervals. Intracellular
fluorescent bacteria were observed in the image corresponding to 30 min post inoculation,
suggesting that internalization occurred within 30 minutes (Figure 2.4). The irregular
shape of the fluorescence in the host cell indicated that it represented a bacterial aggregate.
This agreed with the characteristics of fimbriated strains of A. actinomycetemcomitans,
which tend to form cell aggregates [10].
Intracellular bacteria from the same dendritic cell were also present in the image
corresponding to 60 minutes post inoculation (Figure 2.4). Interestingly, there were two
bacterial clumps of bacteria in the 60 min image compared to a single clump in the 30
min image. This suggested that the bacteria survived and possibly replicated inside
dendritic cells during that 30 min period. One of the cell aggregates appeared to be
migrating to the border between the host cell and the adjacent cell, suggesting it was
egressing from the host. These data suggested that this bacterium was able to survive and
replicate in dendritic cells. The potential transmission of A. actinomycetemcomitans
between host cells was also suggested by these images.
Flow cytometry. In order to expand our finding from individual dendritic cell to
the whole cell population, dendritic cells co-cultured with GFP-expressing A.
actinomycetemcomitans or E. coli with the same plasmid for 6 h were analyzed by flow
cytometry. Consistent with the confocal images, dendritic cells were associated with A.
actinomycetemcomitans (Figure 2.5). Dendritic cells co-cultured with E. coli harboring
the same GFP construct displayed a 50% decrease in the fluorescence intensity compared
to A. actinomycetemcomitans. Considering the phagocytic nature of dendritic cells, a set
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of dendritic cells were treated with 5 µg/mL Cytochalasin D, an actin polymerization
inhibitor, and co-cultured with the same amount of A. actinomycetemcomitans and E.
coli. The dendritic cells treated with Cytochalasin D displayed a 90% decrease and an
80%

decrease

in

fluorescence

intensity

for

those

co-cultured

with

A.

actinomycetemcomitans and with E. coli, respectively. This difference suggested that
actin polymerization of the dendritic cells plays an important role in the uptake of bacteria.
Dendritic cells express multiple C-type lectin receptors, such as Dectin-1, Langerin
and

DC-SIGN

(CD209),

for

the

internalization

of

pathogens

[13].

A.

actinomycetemcomitans expresses a glycoprotein EmaA as surface structures [14]. This
lead us to hypothesize that EmaA binds to C-type lectin receptors via glycoprotein –
lectin interaction, which facilitates the internalization into dendritic cells. To test this
hypothesis, we constructed an isogenic emaA mutant by allelic replacement, labeled it
with the same GFP-expression vector and co-cultured it with dendritic cells in parallel
with the wild type strain. From our result (Figure 2.6), we found that the dendritic cells
co-cultured with emaA mutant had ~70% decrease in fluorescence compared to the wild
type. This decrease in fluorescent intensity was not observed when the morC mutant
strain was co-cultured with dendritic cells. These results suggested that EmaA plays an
important role in the internalization of A. actinomycetemcomitans into dendritic cells.
Live bacteria recovery. We set out to determine the number of live bacteria
inside dendritic cells by gentamicin protection assay. We found a 70% decrease of the
number of live emaA mutant cells from the dendritic cells compared to the wild type cells
(Figure 2.7). This decrease was not present when the morC mutant strain was added to
the cultures (Figure 2.7). These results further supported the hypothesis that A.
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actinomycetemcomitans survives inside dendritic cells and EmaA has a role in the
internalization of A. actinomycetemcomitans into dendritic cells.
In order to confirm the role of EmaA in dendritic cell internalization, we
complemented the emaA mutant in trans by introducing pKM9, a shuttle plasmid
containing the full-length emaA with its endogenous promoter, into the emaA mutant
strain [15]. The emaA complemented strain was included in the gentamicin protection
assay. We found that the complementation of emaA restored the phenotype of the emaA
mutant strain (Figure 2.8). This experiment confirmed the role of EmaA in dendritic cell
internalization.
The genotype of emaA is closely associated with the serotypes of A.
actinomycetemcomitans [16]. Serotype b and c strains express a full-length EmaA
whereas serotype a and d strains express an intermediate form of EmaA with an internal
deletion in the stalk domain (Figure 1.5). To determine if the molecular form of EmaA
is

a

requirement

for

internalization

by

dendritic

cells,

strains

of

A.

actinomycetemcomitans expressing the intermediate form of EmaA were used in the live
bacteria recovery assay. Interestingly, we found an 84% and 91% decrease of the live
bacteria recovered from dendritic cells co-cultured with a serotype a and a serotype d
strain, respectively (Figure 2.9). The number of live bacteria was less than the emaA
mutant from the serotype b. This suggests that dendritic cell internalization and survival
within A. actinomycetemcomitans varies among strains and may depend on the molecular
form or the composition of the glycan of EmaA.
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Table 1. Bacteria strains used in this study

Strains

Description

References

A. actinomycetemcomitans
VT1257

Wild type, formerly IDHaas10a, serotype b
clinical isolate

IDH‡

KM596

VT1257 transformed with plasmid pKM542

This study

KM696

emaA mutant in VT1257, spectinomycin
adenyltransferase gene (aad9) inserted into a
unique HindIII site of emaA

This study

KM695

KM696 transformed with plasmid pKM542

This study

KM732

emaA mutant complemented with plasmid
pKM9

This study

VT1230

Wild type, formerly IDH2303, serotype a
clinical isolate

IDH

VT1246

Wild type, formerly IDH3863, serotype d
clinical isolate

IDH

KM700

morC mutant in VT1257, the morC gene is
replaced
with
spectinomycin
adenyltransferase gene (aad9)

This study

F–
mcrA
Δ(mrr-hsdRMS-mcrBC)
Φ80lacZΔM15 ΔlacX74 recA1 endA1
araD139 Δ(ara leu) 7697 galU galK rpsL
nupG λ–

Invitrogen,
Carlsbad,
CA

E. coli
DH10B
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DH5α (λ pir)

endA1 hsdR17 (r-m+) supE44 thi-1 recA1
gyrA1(Nalr)relA1D(lac-IZYAargF)U169
deoR (F80 dLacD(lacZ)M15) pir R6K

Invitrogen,
Carlsbad,
CA

KM9

DH10B transformed with plasmid pKM9

[17]

KM482

(F-) RP4-2-Tc::Mu Δ(dapA)::(erm-pir), Kmr,
Emr

This study

KM524

KM482 transformed with plasmid pKM524

This study

KM542

DH5α transformed with plasmid pKM542

[3]

KM551

pKM482 transformed with plasmid pKM550

In press

‡Institue of Dentistry, Helsinki, Finland.
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Table 2. Plasmids used in this studya

Plasmids

a

Description

References

pKM1

Shuttle vector, the plasmid pDMG4 with its
spectinomycin adenyltransferase (aad9) replaced
by the aminoglycoside phosphotransferase gene
(kan), Kmr

[18]

pKM9

Full length emaA with 500bp upstream region in
pKM1

[18]

pVT1460

Conjugative vector, a derivative of pGP704,
containing the aminoglycoside phosphotransferase
gene (kan), Kmr

[19]

pKM524

pVT1460 containing the emaA knockout construct,
Spr, Kmr

This study

pKM542

Formerly pNP3, gfp gene in pMMB67 under the
control of spc and tac promoters, Apr

[3], [17]

pKM551

pVT1460 containing the morC knockout construct,
Spr, Kmr

This study

Ap, ampicillin; Km, Kanamycin; Sp, Spectinomycin
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Figure legends
Figure 2.1. Characterization of the emaA mutant by immunoblotting.
Membrane samples with equal amount of protein (250 µg/mL, determined by BCA assay)
from each bacterial strain were loaded onto a 5% SDS-polyacrylamide gel and run at 40
V for 3 h. The proteins were transferred onto PVDF membrane and probed by anti-EmaA
stalk monoclonal antibody. (WT, Wild type; Mut, Mutant)
Figure 2.2. Characterization of the morC mutant by immunoblotting. Whole
cell lysates with equal amount of protein (250 µg/mL, determined by BCA assay) were
loaded onto SDS-polyacrylamide gels and run at 80V for 1.5 h. The proteins were
transferred onto PVDF membrane and probed with affinity purified anti-MorC
polyclonal antibody. (WT, wild type; Mut, Mutant)
Figure 2.3. Confocal microscopy of the dendritic cells co-cultured with A.
actinomycetemcomitans. Mouse BMDCs were grown in GM-CSF and co-cultured with
GFP-labeled A. actinomycetemcomitans. After the co-culture, the nuclei of the dendritic
cells were stained with Hoechst 33324 and the mitochondria were stained with
Mitotracker Red. The dendritic cells were fixed with 2% paraformaldehyde and
visualized by confocal microscopy 0 h (a, b, c), 3 h (d, e, f) and 6 h (g, h, i) after the
inoculation of the bacteria.
Figure

2.4.

Live

actinomycetemcomitans.

imaging
Mouse

of

dendritic

BMDCs

cells

co-cultured

co-cultured
with

with

A.

GFP-labeled

A.

actinomycetemcomitans were imaged by a live imaging system. Images from the same
field were acquired in 1 minute intervals and the images representing 0 min, 15 min, 30
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min and 60 min after the inoculation of the bacteria were presented. The expanded view
of the images taken at 30 min and 60 min after inoculation were also presented.
Figure 2.5. Flow cytometry of dendritic cells with internalized bacteria.
Dendritic cells were either treated with 5 µg/mL Cytochalasin D or left untreated and cocultured with A. actinomycetemcomitans or E. coli. Dendritic cells co-cultured with A.
actinomycetemcomitans were fixed with 2.5% paraformaldehyde and the cells were
scanned by flow cytometry according to the fluorescence intensity from the fluorescent
bacteria associated with the cells.
Figure 2.6. Flow cytometry of dendritic cells co-cultured with various strains.
Equal amount of wild type A. actinomycetemcomitans, emaA mutant A.
actinomycetemcomitans, morC mutant A. actinomycetemcomitans and E. coli were
labeled with the same GFP expression plasmid and inoculated into dendritic cell culture
with the same protein amount. After the co-culture, dendritic cells were fixed with 2.5%
paraformaldehyde and scanned by flow cytometry.
Figure 2.7. Live bacteria recovered from dendritic cells. Mouse BMDCs were
co-cultured with equal amount of the wild type A. actinomycetemcomitans, emaA mutant
(emaA-) or another mutant for an inner membrane protein (morC-). Gentamicin was
added into the co-culture system 2 h after the addition of the bacteria. Dendritic cells with
internalized bacteria were lysed with 0.5% triton X-100 in PBS and the cell lysate was
diluted and spread onto TBSYE plates. The plates were incubated for 72 h to recover the
bacteria and the bacterial colonies were enumerated.
Figure 2.8. Live bacteria recovery of the emaA complemented strain. The emaA
mutant was complemented in trans by transforming a plasmid harboring the full-length
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emaA gene with its endogenous promoter. Equal amount of the wild type, emaA mutant
and the complemented strain were inoculated into the dendritic cell culture for the
gentamicin protection assay.
Figure 2.9. Serotype variation of A. actinomycetemcomitans recovered from
dendritic cells. Serotype a, b and d strains that correlated to 40 µg of total protein were
individually co-cultured with mBMDCs for 3 hours. Dendritic cells were then collected,
lysed and the cell lysates were diluted and spread onto TSBYE plates. The plates were
incubated for 72 hours and CFUs were enumerated.
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Figure 2.1. Characterization of the emaA mutant by immunoblotting.
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Figure 2.2. Characterization of the morC mutant by immunoblotting.
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Figure 2.3. Confocal microscopy of the dendritic cells co-cultured with A. actinomycetemcomitans.
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Figure 2.4. Live imaging of dendritic cells co-cultured with A. actinomycetemcomitans
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Figure 2.5. Flow cytometry of dendritic cells with internalized bacteria.
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Figure 2.6. Flow cytometry of dendritic cells co-cultured with various strains.
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Figure 2.7. Live bacteria recovered from dendritic cells.
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Figure 2.8. Live bacteria recovery of the emaA complemented strain.
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Figure 2.9. Serotype variation of live bacteria recovered from dendritic cells.
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CHAPTER 3: DISCUSSION AND FUTURE DIRECTIONS
3.1. Discussion
In this research, the interaction of the Gram-negative oral pathogen A.
actinomycetemcomitans with bone marrow-derived dendritic cells was investigated in an
in vitro internalization assay. GFP-expressing bacteria were co-cultured with dendritic
cells and after several hours, A. actinomycetemcomitans was found inside dendritic cells
and suggested to be replicating (Figure 2.3, 2.4). The internalized bacteria were found in
a perinuclear localization in dendritic cells, which suggests that the internalized A.
actinomycetemcomitans are in vacuoles. Both phagocytosis and receptor mediated
endocytosis form membrane bound vacuoles following particle uptake and the content of
the vacuoles are destined for degradation along the phagolysosome pathway [1]. These
vacuoles mature by membrane fusion events with smaller vacuoles originated from the
Golgi and ER, which contain enzymes associated with the degradation of the content of
the vacuoles [1]. The ER is contiguous with the nucleus and this may explain the
intracellular localization of the bacteria. Furthermore, the absence of randomly
distributed bacteria in the cell suggests that A. actinomycetemcomitans does not escape
from the vacuoles and may usurp the phagolysosome pathway for persistence and
survival within the dendritic cells.
Fluorescent bacteria observed inside dendritic cells in the image corresponding to
30 minutes post inoculation suggests that the uptake of the bacteria can be accomplished
within 30 minutes (Figure 2.4). Bacterial aggregates were observed within dendritic cells.
Based on the known doubling time of A. actinomycetemcomitans and the co-culture
period, bacterial aggregates appear to be internalized. However, we cannot exclude the
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possibility that individual bacteria may also be found in dendritic cells. A study of the
interaction of A. actinomycetemcomitans with neutrophils suggests that bacterial
aggregates are less efficiently internalized compared to single bacterium, possibly due to
the large size of the aggregates or the less efficient interaction of bacteria with host cells
[6]. Moreover, the auto-aggregation may contribute to the intracellular survival of A.
actinomycetemcomitans within dendritic cells by protecting the bacteria from the low pH
and the enzymes in the phagolysosomes.
Approximately twice the amount of fluorescent A. actinomycetemcomitans was
associated with dendritic cells compared to E. coli when starting with equivalent
inoculum (Figure 2.5). This difference does not appear compelling per se. However, the
significance of this finding is greatly enhanced if the different growth rates of these two
organisms are taken into consideration. For a single doubling time of A.
actinomycetemcomitans (~150 minutes), E. coli undergoes 7 divisions (~20 minutes).
Therefore, over the life time of the experiment (3 hours), there should be ~8 times the
number of E. coli associated with dendritic cells than A. actinomycetemcomitans if both
bacteria were affected to the same extent inside dendritic cells. However, a 50%
reduction in the fluorescent intensity of the E. coli cells was observed, in sharp contrast
to the growth rate of each bacterium. These data suggest that A. actinomycetemcomitans
survives more efficiently than E. coli in dendritic cells.
There are two possible explanations for this observed difference between these two
organisms. The first possibility is A. actinomycetemcomitans is more robust than E. coli.
This is highly unlikely as A. actinomycetemcomitans is not viable after 4 days in culture
whereas E. coli survives more than 6 months at 4ºC. The second possibility is A.
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actinomycetemcomitans has a higher survival capability within dendritic cells compared
to E. coli. Multiple co-evolved mechanisms, such as delivering effectors molecules to the
host cell and interfering the phagolysosome formation, are utilized by bacteria to survive
in host cells. The mechanisms used by A. actinomycetemcomitans for survival within
dendritic cells remain to be investigated.
Dendritic cells, along with neutrophils and macrophages, are professional
phagocytic cells playing a key role in the innate immune system [4]. The interaction of
A. actinomycetemcomitans with neutrophils and macrophages has been investigated in
similar in vitro internalization assays [5, 6]. A. actinomycetemcomitans is rapidly killed
after being internalized into neutrophils and macrophages [5, 6]. In contrast, A.
actinomycetemcomitans appears to persist or survive within dendritic cells. The
differences in persistence may be attributed to the different functions and physiologies
of the immune cells. Neutrophils and macrophages are very efficient in scavenging and
destroying phagocytized particles [7]. Neutrophils are the first group of phagocytic cells
that migrate to the infectious foci through chemotaxis followed by macrophages.
Following internalization of the pathogens, an oxidative burst is induced generating
various toxic compounds such as hydrogen peroxide, superoxide ions and free radicals
which kill the internalized microbes [8]. Macrophages also degrade the phagocytized
particles by a rapid fusion of the lysosome with the phagosome. In contrast, dendritic
cells tend to preserve and accumulate antigens for antigen presentation [7]. In correlation
with this unique role, dendritic cells have a lower amount of lysosomal proteases and a
lower level of lysosomal proteolysis [8]. These differences may contribute to the alternate
intracellular fate of A. actinomycetemcomitans in different cells.
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The internalization of A. actinomycetemcomitans by dendritic cells is mediated by
the EmaA structures. Mutational inactivation of emaA results in a 70% decrease of
bacteria observed in dendritic cells compared to the wild type, which can be restored by
in trans complementation (Figure 2.8). We hypothesize that the EmaA structures interact
with receptors on the dendritic cell surface and the bacteria are taken up in vacuoles. The
mutation of emaA did not completely abolish the internalization, indicating that other
bacterial surface proteins may be involved and that the bacteria are also internalized
through non-specific uptake by phagocytosis.
Dendritic cells express multiple C-type lectin receptors for the internalization of
bacteria. A Gram-negative oral pathogen, Porphyromonas gingivalis, is internalized into
dendritic cells by its minor fimbriae [11]. The minor fimbriae are composed of repeating
67 kDa protein monomers Mfa1 [11]. Mfa1 is found to be glycosylated and the
carbohydrate moiety contains fucose, mannose, N-acetylglucosamine and Nacetylgalactosamine, which are known ligands for the lectin receptor, Dendritic cellspecific ICAM3-grabbing nonintegrin (DC-SIGN) [12]. Interestingly, EmaA is also a
glycoprotein and we hypothesize that the glycan moiety by itself or in combination with
the protein structure is required for the interaction with the C-type lectin receptors on the
surface of dendritic cells. The glycan moiety of EmaA is suggested to be composed of
sugars associated with the O-PS of the LPS, which includes L-rhamnose, D-fucose and
N-acetyl-D-galactosamine [14]. Two of the three sugars are also ligands for DC-SIGN.
These findings suggest that the EmaA expressed by serotype b strains may interact with
DC-SIGN. On the other hand, dendritic cells also express other lectin receptors, including
Dectin-1 and Langerin. Whether EmaA binds to one or multiple specific receptors to
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facilitate the internalization of A. actinomycetemcomitans into dendritic cells remains to
be determined.
We found that the number of serotype b A. actinomycetemcomitans recovered from
dendritic cells were at least five fold higher compared to the serotype a and serotype d
strains (Figure 2.9). Different serotypes of A. actinomycetemcomitans are categorized by
different composition of O-polysaccharide. The difference in the internalization among
these strains may be due to the fact that VT1230 (serotype a) and VT1246 (serotype d)
express different molecular forms of EmaA on the surface of the bacteria, as verified by
immunoblotting and electron microscopy [8]. These molecules are suggested to vary in
structure as compared with the serotype b or the full-length EmaA, due to the 279 amino
acid deletion in the stalk domain in addition to the amino acid sequence difference in the
adhesin moiety [9]. Therefore, structural differences may exist which impact the
receptor-ligand interaction. In addition, the sugars associated with the EmaA structures
of these serotypes may not be specific for the dendritic cell lectin receptors. Further
investigations are warranted to address these questions.
Another possibility for the decreased recovery is that the serotypes of A.
actinomycetemcomitans contain ~20% sequence variation in the genome, which may
lead to potential phenotypical variations. The serotype b strain may express unique outer
membrane proteins or virulence factors that are absent in serotype a or serotype d, which
contributes to the internalization and intracellular survival of the serotype b strains.
In conclusion, we demonstrated by three independent yet complementary
approaches that A. actinomycetemcomitans is internalized into dendritic cells and survive
intracellularly. We also demonstrated that the surface glycoprotein EmaA is critical in
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the internalization process, possibly by binding to the lectin receptors on dendritic cells
through glycoprotein – lectin interaction and induce the subsequent uptake. In addition,
bacterial internalization or survival is dependent on the serotype of the organism,
possibly due to the different molecular forms or posttranslational modification of EmaA.
The survival of A. actinomycetemcomitans in dendritic cells provides a putative
mechanism for the immune evasion and dissemination of this oral bacterium from the
periodontal tissues to distant organs of the body.
3.2. Future directions
Determine the role of EmaA molecular forms in dendritic cell internalization
of A. actinomycetemcomitans. The genotype of emaA is closely associated with the
serotype of the bacteria. Serotype b and c strains encode a full-length EmaA, whereas
serotype a and d strains encode an intermediate form of EmaA [8]. Both forms of EmaA
form surface structures and bind to collagen. However, the question still remains whether
the

intermediate

form

of

EmaA

mediates

the

internalization

of

A.

actinomycetemcomitans into dendritic cells. We attempted to address this question in our
research, however, the different survival rates of the different serotypes prevented us
from dissecting the role of EmaA independent from the genome variation and different
intracellular survival between different strains. In order to maintain a consistent genetic
background among the strains in the study, we need to transform a plasmid harboring the
gene encoding the intermediate form of EmaA into the emaA mutant serotype b strain.
We will include the strain expressing the intermediate form of EmaA in the dendritic cell
internalization assay and compare the internalization efficiency to the wild type and
emaA mutant. We expect that the intermediate form of EmaA is able to mediate the
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internalization of the bacterium into dendritic cells to a comparable level with the wild
type strain.
Determine the role of EmaA glycosylation in dendritic cell internalization.
EmaA is post-translationally glycosylated by the shared O-PS biosynthesis pathway [14].
The glycosylation of EmaA is required for the stability of the molecule and the collagen
binding activity. We hypothesize that EmaA interacts with the lectin receptor(s) on
dendritic cells via a glycoprotein-lectin interaction. To test our hypothesis, an A.
actinomycetemcomitans strain expressing glycosylation deficient EmaA will be
generated by disrupting the waaL gene. Overexpression of emaA in this mutant increases
the level of EmaA to wild type levels but the defect in collagen binding still remains [15].
This suggests that the glycosylation is required for the function of EmaA. We will use
this overexpression strain expressing the deglycosylated form of EmaA in the dendritic
cell internalization assay to compare the dendritic cell internalization efficiency with the
wild type strain and the emaA mutant strain. We expect the mutant harboring the
deglycosylated EmaA will have a decreased rate of dendritic cell internalization that is
comparable to the emaA mutant strain.
Determine the relationship between collagen binding and dendritic cell
internalization of EmaA. The mature EmaA consists of three domains, including a Nterminal functional domain, which forms an ellipsoidal structure as is revealed by
electron microscopy [9, 23]. The functional domain is followed by a long stalk domain,
which contains sequences for the formation of coiled-coil structures. The C-terminus of
the protein contains β-barrel folds that forms the membrane-anchor domain that
facilitates the secretion of the protein out of the outer membrane. The collagen binding
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activity of EmaA has been linked to the head domain of EmaA, which contains amino
acids 70-384. Transforming plasmids harboring emaA sequences containing partial
deletions were not able to complement the phenotype. There are multiple collagen
binding motifs located in the head domain, which begin with either a serine or a glycine,
three hydrophobic amino acids and ended with a glycine. A single point mutation in the
collagen binding motif is sufficient to abolish the collagen binding activity of EmaA.
However, we do not know whether the active domain for dendritic cell internalization
overlaps with the collagen binding domain. Those isogenic mutants expressing the
mutant EmaA will be used in the dendritic cell internalization assay and compared with
the wild type and emaA mutant to determine the link between the collagen binding and
dendritic cell internalization.
Determine the role of additional putative surface molecules in dendritic cell
internalization. Besides EmaA, A. actinomycetemcomitans also express multiple surface
proteins including the bundled fimbriae and non-fimbrial adhesins ApiA and Aae.
Interestingly, the subunit of the fimbriae, Flp1, is also suggested to be glycosylated,
possibly by a protein RcpC which is encoded downstream in the tad locus [19, 20].
Therefore, the fimbria of A. actinomycetemcomitans is another putative surface structure
involved in dendritic cell internalization. The role of the fimbriae in dendritic cell
internalization can be determined by comparing a flp-1 mutant strain with the wild type
in the dendritic cell internalization assay. An rcpC mutant will also be constructed to
determine the role of Flp1 modification in the internalization process. The other two nonfimbrial adhesins, i.e. ApiA and Aae, are involved in the adhesion of epithelial cells [26].
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The role of these two adhesins in dendritic cell internalization can be determined using
the respective isogenic mutant in the same manner.
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